AR and posterior cortical atrophy: More recently, Cucchiara and coworkers demonstrated that the GnRH antagonist degarelix significantly reduces the proliferation of C4-2-MDVR (castration- and enzalutamide-resistant) PCa cells expressing the androgen receptor variant AR-V7.